BioCentury
ARTICLE | Company News

Baxter NDA accepted for filing

February 22, 2001 8:00 AM UTC

The FDA accepted for filing BAX's NDA for Extraneal peritoneal dialysis (PD) solution for use in the treatment of end stage renal disease. The solution is currently marketed in 28 countries. BAX licen...